{
    "applicationNumber": "BR 11 2022 003568-3",
    "filingDate": "02/09/2020",
    "grantDate": null,
    "title": "MEMBRO DE LIGA\u00c7\u00c3O ESPEC\u00cdFICA ISOLADO, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, PRODUTOS, E \u00c1CIDO NUCLEICO",
    "nationalPhaseDate": [
        "24/02/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2020/074441",
        "pctDate": "02/09/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "GB",
            "priorityNumber": "1912657.2",
            "priorityDate": "03/09/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2670"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2681"
        }
    ],
    "inventors": [
        "LINDA GILLIAN DURRANT"
    ],
    "holders": [
        150850
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 39/395",
        "C07K 16/30"
    ]
}